GlobalPharma AG

Oncology mRNA Vaccine Development Partnership

The client required rapid scale-up of their Oncology therapeutic with aggressive timelines and complex analytical requirements.

We deployed our experienced team and state-of-the-art facilities to develop a robust manufacturing process. Key innovations included process intensification and real-time analytics.

The program achieved all milestones on schedule. The product received regulatory approval and is now in commercial production.

Infectious Disease Gene Therapy Development Partnership

The client required rapid scale-up of their Infectious Disease therapeutic with aggressive timelines and complex analytical requirements.

We deployed our experienced team and state-of-the-art facilities to develop a robust manufacturing process. Key innovations included process intensification and real-time analytics.

The program achieved all milestones on schedule. The product received regulatory approval and is now in commercial production.

Dermatology mRNA Vaccine Development Partnership

The client required rapid scale-up of their Dermatology therapeutic with aggressive timelines and complex analytical requirements.

We deployed our experienced team and state-of-the-art facilities to develop a robust manufacturing process. Key innovations included process intensification and real-time analytics.

The program achieved all milestones on schedule. The product received regulatory approval and is now in commercial production.

Sterile Fill-Finish Process Validation

The client required rapid scale-up while maintaining strict quality standards and regulatory compliance. Time-to-market was critical.

Our team implemented innovative process optimization techniques, leveraged advanced manufacturing technologies, and established robust quality control systems.

Project completed 30% faster than industry average with zero quality deviations. Client achieved regulatory approval on first submission.